tirzepatide and kidney disease New Trial Studying for Chronic Tirzepatide Associated with Lower Risk

Archives of Disease in Childhood

As a glucagon-like peptide-1 receptor agonist, semaglutide works by mimicking the effects of GLP-1, a naturally occurring hormone that regulates blood sugar and appetite

Un metaanlisis en red de rango de dosis encontr que la tirzepatida en su dosis mxima tolerada produjo la mayor reduccin de peso promedio (aproximadamente 20.9%) de cualquier dosis probada, por delante de la dosis mxima tolerada de la semaglutida (aproximadamente 14.4%)

Some treatment options may not be safe to take with your other medications or other medical conditions

Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF (2003) Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study

Why this study is important This is the first headtohead randomized comparison of a dual GIP/GLP1 agonist vs a selective GLP1 RA on kidney outcomes